254 related articles for article (PubMed ID: 20619251)
21. Androsterone 3alpha-ether-3beta-substituted and androsterone 3beta-substituted derivatives as inhibitors of type 3 17beta-hydroxysteroid dehydrogenase: chemical synthesis and structure-activity relationship.
Tchédam Ngatcha B; Luu-The V; Labrie F; Poirier D
J Med Chem; 2005 Aug; 48(16):5257-68. PubMed ID: 16078844
[TBL] [Abstract][Full Text] [Related]
22. The inhibitory effects of perfluoroalkyl substances on human and rat 11β-hydroxysteroid dehydrogenase 1.
Ye L; Zhao B; Cai XH; Chu Y; Li C; Ge RS
Chem Biol Interact; 2012 Jan; 195(2):114-8. PubMed ID: 22178014
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
[TBL] [Abstract][Full Text] [Related]
24. Development of 3-substituted-androsterone derivatives as potent inhibitors of 17β-hydroxysteroid dehydrogenase type 3.
Maltais R; Fournier MA; Poirier D
Bioorg Med Chem; 2011 Aug; 19(15):4652-68. PubMed ID: 21741247
[TBL] [Abstract][Full Text] [Related]
25. The design of novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors.
Vicker N; Sharland CM; Heaton WB; Gonzalez AM; Bailey HV; Smith A; Springall JS; Day JM; Tutill HJ; Reed MJ; Purohit A; Potter BV
Mol Cell Endocrinol; 2009 Mar; 301(1-2):259-65. PubMed ID: 18775469
[TBL] [Abstract][Full Text] [Related]
26. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
27. Effects of a 3beta-hydroxysteroid dehydrogenase inhibitor, trilostane, on the fathead minnow reproductive axis.
Villeneuve DL; Blake LS; Brodin JD; Cavallin JE; Durhan EJ; Jensen KM; Kahl MD; Makynen EA; Martinovic D; Mueller ND; Ankley GT
Toxicol Sci; 2008 Jul; 104(1):113-23. PubMed ID: 18397916
[TBL] [Abstract][Full Text] [Related]
28. Corticosterone impairs the mRNA expression and activity of 3beta- and 17beta-hydroxysteroid dehydrogenases in adult rat Leydig cells.
Badrinarayanan R; Rengarajan S; Nithya P; Balasubramanian K
Biochem Cell Biol; 2006 Oct; 84(5):745-54. PubMed ID: 17167538
[TBL] [Abstract][Full Text] [Related]
29. Effects of polychlorinated biphenyl (Aroclor 1254) on steroidogenesis and antioxidant system in cultured adult rat Leydig cells.
Murugesan P; Balaganesh M; Balasubramanian K; Arunakaran J
J Endocrinol; 2007 Feb; 192(2):325-38. PubMed ID: 17283232
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of 3-spiromorpholinone androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.
Djigoué GB; Kenmogne LC; Roy J; Poirier D
Bioorg Med Chem Lett; 2013 Dec; 23(23):6360-2. PubMed ID: 24144853
[TBL] [Abstract][Full Text] [Related]
31. Triphenyltin and Tributyltin inhibit pig testicular 17beta-hydroxysteroid dehydrogenase activity and suppress testicular testosterone biosynthesis.
Ohno S; Nakajima Y; Nakajin S
Steroids; 2005 Aug; 70(9):645-51. PubMed ID: 15899506
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of human and rat testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD) as potential agents for prostatic cancer.
Le Lain R; Nicholls PJ; Smith HJ; Maharlouie FH
J Enzyme Inhib; 2001 Jan; 16(1):35-45. PubMed ID: 11496833
[TBL] [Abstract][Full Text] [Related]
33. Flavonoid inhibition of overexpressed human 3beta-hydroxysteroid dehydrogenase type II.
Ohno S; Matsumoto N; Watanabe M; Nakajin S
J Steroid Biochem Mol Biol; 2004 Feb; 88(2):175-82. PubMed ID: 15084349
[TBL] [Abstract][Full Text] [Related]
34. Transient inhibitory effect of methoxychlor on testicular steroidogenesis in rat: an in vivo study.
Vaithinathan S; Saradha B; Mathur PP
Arch Toxicol; 2008 Nov; 82(11):833-9. PubMed ID: 18401575
[TBL] [Abstract][Full Text] [Related]
35. Design, chemical synthesis and biological evaluation of 3-spiromorpholinone/3-spirocarbamate androsterone derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase type 3.
Djigoué GB; Kenmogne LC; Roy J; Maltais R; Poirier D
Bioorg Med Chem; 2015 Sep; 23(17):5433-51. PubMed ID: 26277760
[TBL] [Abstract][Full Text] [Related]
36. Effect of lead on male gonadal activity in albino rats.
Biswas NM; Ghosh P
Kathmandu Univ Med J (KUMJ); 2004; 2(1):43-6. PubMed ID: 19780287
[TBL] [Abstract][Full Text] [Related]
37. Immunolocalization of 3beta-HSD and 17beta-HSD in the testis of the spotted ray Torpedo marmorata.
Prisco M; Liguoro A; Ricchiari L; Del Giudice G; Angelini F; Andreuccetti P
Gen Comp Endocrinol; 2008 Jan; 155(1):157-63. PubMed ID: 17561019
[TBL] [Abstract][Full Text] [Related]
38. Disrupting androgen production of Leydig cells by resveratrol via direct inhibition of human and rat 3β-hydroxysteroid dehydrogenase.
Li L; Chen X; Zhu Q; Chen D; Guo J; Yao W; Dong Y; Wei J; Lian Q; Ge RS; Yuan B
Toxicol Lett; 2014 Apr; 226(1):14-9. PubMed ID: 24472608
[TBL] [Abstract][Full Text] [Related]
39. Structure-based design, synthesis and in vitro characterization of potent 17beta-hydroxysteroid dehydrogenase type 1 inhibitors based on 2-substitutions of estrone and D-homo-estrone.
Möller G; Deluca D; Gege C; Rosinus A; Kowalik D; Peters O; Droescher P; Elger W; Adamski J; Hillisch A
Bioorg Med Chem Lett; 2009 Dec; 19(23):6740-4. PubMed ID: 19836949
[TBL] [Abstract][Full Text] [Related]
40. Chalcones are potent inhibitors of aromatase and 17beta-hydroxysteroid dehydrogenase activities.
Le Bail JC; Pouget C; Fagnere C; Basly JP; Chulia AJ; Habrioux G
Life Sci; 2001 Jan; 68(7):751-61. PubMed ID: 11205867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
